Back to Capitolis Liquid Global Markets LLC Capitolis Liquid Global Markets LLC

SYRESYRE

2 quarters

Position history for Capitolis Liquid Global Markets LLCCapitolis Liquid Global Markets LLC's holdings in Spyre Therapeutics, Inc.

No. Capitolis Liquid Global Markets exited its SYRE (Spyre Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 183,000 shares worth $2.7M. Capitolis Liquid Global Markets first reported SYRE in Q2 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$2.7M

Total Shares Change

-183,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$16.76
0
2025-Q2
New
183,000
—
$2.7M0.0%$14.97
36

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used